About the Ocular Oncology and Eye Tumours Session
Ocular tumors, often known as eye tumors, are tumors that affect the eyes. A tumor is a collection of abnormally growing cells that can be either malignant (cancerous) or benign (non-cancerous) (noncancerous). Metastatic eye tumors are the most prevalent type of eye tumor. The study and treatment of cancers in or around the eye is referred to as ocular oncology. These tumors can range from benign to life-threatening, and they can result in vision loss or the loss of the eye itself. Ocular care for people with eye cancer is a unique field. Certainly, the difficulties encountered are not the same as those encountered in a regular ophthalmic practice.
- Biomarkers and Early Detection of Cancers
- Adjuvant Therapies
- Improved Visual Outcomes After Ocular Melanoma Treatment
- Clinical Care
- Types of Ocular Tumors
- Challenges of Ocular Oncology
Topics Covered in Ocular Oncology and Eye Tumours
Choroidal Metastases
Choroidal Nevus & Melanoma
Conjunctival Tumors
Eyelid Malignancies
Early Detection Biomarkers
Plaque Brachytherapy
Related Scientific Sessions at IOC 2027
Why Attend the Ocular Oncology and Eye Tumours Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Ocular Oncology and Eye Tumours work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Ocular Oncology and Eye Tumours research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Ocular Oncology and Eye Tumours track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ocular Oncology and Eye Tumours Conference 2027 — FAQs
What is the Ocular Oncology and Eye Tumours track at IOC 2027?
The Ocular Oncology and Eye Tumours track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ocular Oncology and Eye Tumours. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ocular Oncology and Eye Tumours sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ocular Oncology and Eye Tumours are all welcome — whether presenting or attending.
Can I present my research in the Ocular Oncology and Eye Tumours track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ocular Oncology and Eye Tumours sessions?
Yes. IOC 2027 is a hybrid conference — attend the Ocular Oncology and Eye Tumours track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.